Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients

Abroad (travel likely)RecruitingPHASE2

Conditions

End Stage Renal Disease on Dialysis · Peritoneal Dialysis Complication · Sodium-glucose Cotransporter-2 Inhibitor · Residual Kidney Function

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Chinese University of Hong Kong, Hong Kong, Hong Kong
Contact: Study coordinator (Jack KC Ng, FRCP) · jackng@cuhk.edu.hk · 85237636098

Study leads

Jack KC Ng, FRCP
Principal Investigator
Chinese University of Hong Kong
Cheuk Chun Szeto, MD, FRCP
Study Director
Chinese University of Hong Kong

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease

End Stage Renal Disease on Dialysis

Abroad (travel likely)RecruitingPHASE4

New Haven, United States

meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis

Peritoneal Dialysis Complication · End Stage Kidney Disease · Sodium-glucose Co-transporter-2 Inhibitors

Abroad (travel likely)RecruitingPHASE3

Toronto, Canada

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

Hyperphosphatemia · Chronic Kidney Disease, Receiving Dialysis · ESRD (End-Stage Renal Disease)

Abroad (travel likely)RecruitingPHASE3

Granada Hills, United States · San Dimas, United States

Behind the Needle: Healthcare Professionals' Perspectives on HD Needling

Perspective of Healthcare Professionals Haemodialysis Needling · Dialysis

Abroad (travel likely)Recruiting

Stevenage, United Kingdom